CAR-T Cell Therapy-Associated Coagulopathy: From Immunothrombotic Storm Mechanisms to Precision Management Strategies.
This review synthesizes current evidence on CARAC pathobiology, emphasizing its dynamic transition from early procoagulant endothelial conversion to secondary hyperfibrinolysis and consumptive coagulopathy.